Investigation of the Postprandial Response of Two Different PDO Cheeses on Metabolic Biomarkers (LadotyriCT)

April 11, 2023 updated by: ANTONIOS KOUTELIDAKIS, University of the Aegean

Postprandial Inflammatory and Metabolic Responses Induced by the Authentic Ladotyri Mytilinis PDO Cheese and Italian Parmesan PDO Cheese

The purpose of this study was the investigation of the postprandial metabolic responses, after the intake of a traditional, Ladotyri Mytilinis cheese, compared to corresponding responses after an Italian Parmesan cheese consumption, in healthy participants.

Study Overview

Status

Completed

Conditions

Detailed Description

A pilot cross-over, randomized and single-blinded, intervention-clinical trial was conducted, in ten healthy men and women subjects, aged eighteen to thirty years, after random allocation into the control and the intervention group, received a high-fat and carbohydrates meal, containing Ladotyri Mytilinis (the authentic nonrefrigerated recipe) or Italian Parmesan, PDO cheeses. After a washout week, participants consumed the same meals, conversely. Differences on postprandial responses of serum total, High Density Lipoprotein (HDL-), Low Density Lipoprotein (LDL-) cholesterol, glucose, triglycerides and uric acid levels, as well as of plasma total antioxidant capacity according to Ferric Reducing Antioxidant Power method, were determined between groups in fasting, thirty minutes, one and a half hour, and three hours after meal intake.

Study Type

Interventional

Enrollment (Actual)

10

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Myrina, Greece, 81 400
        • University of the Aegean

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 65 years (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Age 18-65 years
  • Willingness to join and complete the nutritional intervention

Exclusion Criteria:

  • Inability or unwillingness to provide informed consent
  • Three-month nutritional supplement
  • Age over 65 years or below 18 years
  • Chronic diseases history
  • Hemoglobin A1c - HbA1c > 5.7 %
  • Abnormal Body Mass Index (BMI) (> 25 kg / m2)
  • Abnormal hematological or biochemical profile (total cholesterol > 240 mg/dL, triglycerides > 250 mg/dL, glucose > 100 mg/dL)
  • Alcohol overdose (> 40 g alcohol / day)
  • Heavy smoking (> 10 cigarettes / day)
  • Concurrent participation in another intervention study or unconsciousness in previous blood draws

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Placebo Comparator: Control
The meal contained 100g of white wheat bread and 80g of Italian Parmesan PDO cheese.
Branding Parmesan PDO cheese from Italy, supplied by LIDL Hellas
Other Names:
  • Italian Parmesan
Other: Intervention
The meal contained 100g of white wheat bread and 80g of Authentic Ladotyri Mytilinis PDO cheese.
Branding PDO cheese from Mytilini, purchasing by E.Thimelis Dairy S.A.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Changes from baseline of Total Antioxidant Capacity at 30 minutes, 1.5 hours and 3 hours
Time Frame: 3 hours
Plasma antioxidant activity
3 hours

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Changes from baseline of total Cholesterol at 30 minutes, 1.5 hours and 3 hours
Time Frame: 3 hours
Serum total cholesterol levels
3 hours
Changes from baseline of High Density Lipoprotein cholesterol (HDL-) at 30 minutes, 1.5 hours and 3 hours
Time Frame: 3 hours
Serum High Density Lipoprotein levels
3 hours
Changes from baseline of Low Density Lipoprotein cholesterol (LDL-) at 30 minutes, 1.5 hours and 3 hours
Time Frame: 3 hours
Serum High Density Lipoprotein levels
3 hours
Changes from baseline of triglycerides at 30 minutes, 1.5 hours and 3 hours
Time Frame: 3 hours
Serum triglycerides levels
3 hours
Changes from baseline of glucose at 30 minutes, 1.5 hours and 3 hours
Time Frame: 3 hours
Serum glucose levels
3 hours
Changes from baseline of Uric Acid at 30 minutes, 1.5 hours and 3 hours
Time Frame: 3 hours
Serum uric acid levels
3 hours

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 10, 2022

Primary Completion (Actual)

January 17, 2022

Study Completion (Actual)

January 17, 2022

Study Registration Dates

First Submitted

February 24, 2023

First Submitted That Met QC Criteria

March 16, 2023

First Posted (Actual)

March 29, 2023

Study Record Updates

Last Update Posted (Actual)

April 14, 2023

Last Update Submitted That Met QC Criteria

April 11, 2023

Last Verified

April 1, 2023

More Information

Terms related to this study

Other Study ID Numbers

  • BAP20060569

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

No individual participant data are to be shared.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe